- IN₹229.07bn
- IN₹234.65bn
- IN₹53.66bn
Brief: Granules Completes Acquisition Of Senn Chemicals
Brief: Granules India Approves Internal Restructuring Plan For US Subsidiaries
Brief: Granules India Approves Internal Restructuring Plan For U.S. Subsidiaries
Brief: Granules Says Unit Granules Europe Has Been Voluntarily Dissolved
Granules India falls on receiving US FDA contamination warning
Brief: Granules Gets Order For Closure Of Proceedings Of Investigation After Payment Of Dues
Granules India falls after facility gets warning letter from US FDA
Granules India gains on deal to acquire Switzerland's Senn Chemicals
Brief: Granules India To Acquire 100% Equity Stake In Senn Chemicals AG
Brief: Granules Says FDA Approval For Lisdexamfetamine Dimesylate Capsules
Granules India gains on European manufacturing approval for APIs, finished dosages
Brief: Granules India Says Unit V Receives EU GMP Certificate
India's Torrent Pharma misses Q3 profit estimates, hurt by insulin plant closure
Granules India's Q3 profit falls on weak drug pricing in Europe
Brief: Granules India Q3 Consol Profit 1.18 Bln Rupees
Granules India rises on US FDA nod for unit's ADHD treatment drug
Brief: Granules Announces FDA Approval For ADHD Treatment
Brief: Granules Update On US FDA Inspection At Gagillapur Facility
Granules India falls 10% for second time this year after US FDA gives 'OAI' tag to facility